• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNTHES USA; PLATE, CRANIOPLASTY, PREFORMED, NONALTERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNTHES USA; PLATE, CRANIOPLASTY, PREFORMED, NONALTERABLE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Impaired Healing (2378)
Event Type  Injury  
Manufacturer Narrative
Device was used for treatment, not diagnosis.Additional narrative: (b)(4).This report is for unknown peek/unknown quantity/unknown lot.The investigation could not be completed and no conclusion could be drawn, as no device was returned and no lot number or part number was provided.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Literature article received: this report is being filed after the subsequent review of the following literature article: alonso-rodriguez, e., et al (2015) polyetheretherketone custom-made implants for craniofacial defects: report of 14 cases and review of the literature.Journal of cranio-maxillo-facial surgery 43(2015)1232-1238.A retrospective review was conducted of 14 patients who underwent peek craniofacial reconstruction between 2008 and 2014.Over the 6 years, 14 patients (4 men and 10 women; mean age 42.7 years) underwent craniofacial reconstruction using a peek psi (polyetheretherketone- patient specific implant) due to defects arising from different pathologic conditions including trauma (1 patient), congenital deformities (4 craniofacial dysplasias and 1 facial cleft), and various benign and malignant tumors (8 cases).Postoperative complications were observed in five patients.One patient had a seroma, another patient had a cerebrospinal fluid (csf) leak that was treated conservatively, and two other patients presented with infection.In one of the patients with infection, the implant had to be removed, sterilized, and replaced during a single intervention.In the second infective case, the patient was treated with a 4 week course of antibiotics according to the antibiogram (vancomycin) leading to a full resolution of the symptoms.In a single case, inflammation of the frontal sinus was observed in follow-up imaging, but the patient was asymptomatic, and no treatment was deemed necessary.One wound dehiscence with implant exposure due to cutaneous necrosis was observed.This refers to: patient 3, female, age (b)(6): infection-implant removed and replaced.This is report 1 of 5 for (b)(4).This report is for unknown peek implants.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
PLATE, CRANIOPLASTY, PREFORMED, NONALTERABLE
Manufacturer (Section D)
SYNTHES USA
1302 wrights lane east
west chester PA 19380
Manufacturer Contact
michael cote
1302 wrights lane east
west chester, PA 19380
6107195000
MDR Report Key6252064
MDR Text Key64884427
Report Number2520274-2017-10152
Device Sequence Number1
Product Code GXN
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 12/16/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/13/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received12/16/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age21 YR
-
-